Cargando…

In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model

BACKGROUND: Bee venom (BV), a type of toxin extracted from honeybees (Apis mellifera), has been empirically and widely used to treat inflammatory diseases throughout Asia. Essential BV (eBV) was developed by removing phospholipase A2 (PLA2) and histamine to lower occurrence of allergic reaction. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Hwa-Jin, Lee, Jinho, Shin, Joon-Shik, Kim, Me-riong, Koh, Wonil, Kim, Min-Jeong, Lee, Jae-woong, Kim, Eun Jee, Lee, In-Hee, Kim, Won Kyung, Lee, Yoon Jae, Lee, Sang Kook, Ha, In-Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145209/
https://www.ncbi.nlm.nih.gov/pubmed/27930719
http://dx.doi.org/10.1371/journal.pone.0168120
_version_ 1782473256052195328
author Chung, Hwa-Jin
Lee, Jinho
Shin, Joon-Shik
Kim, Me-riong
Koh, Wonil
Kim, Min-Jeong
Lee, Jae-woong
Kim, Eun Jee
Lee, In-Hee
Kim, Won Kyung
Lee, Yoon Jae
Lee, Sang Kook
Ha, In-Hyuk
author_facet Chung, Hwa-Jin
Lee, Jinho
Shin, Joon-Shik
Kim, Me-riong
Koh, Wonil
Kim, Min-Jeong
Lee, Jae-woong
Kim, Eun Jee
Lee, In-Hee
Kim, Won Kyung
Lee, Yoon Jae
Lee, Sang Kook
Ha, In-Hyuk
author_sort Chung, Hwa-Jin
collection PubMed
description BACKGROUND: Bee venom (BV), a type of toxin extracted from honeybees (Apis mellifera), has been empirically and widely used to treat inflammatory diseases throughout Asia. Essential BV (eBV) was developed by removing phospholipase A2 (PLA2) and histamine to lower occurrence of allergic reaction. This study investigated the anti-allergic and anti-inflammatory activities of eBV in vitro and in vivo and its underlying mechanism of action. METHODS: The anti-inflammatory potential of eBV was assessed in vivo using a carrageenan-induced paw edema model. To further investigate the mechanism by which eBV exerts anti-allergic and anti-inflammatory effects, compound 48/80-stimulated RBL-2H3 cells and lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophage cells were studied in vitro. RESULTS: Release of β-hexosaminidase and histamine was increased by eBV in a dose-dependent manner, but these levels were lower in eBV compared to original BV at the same concentration. In addition, eBV suppressed compound 48/80-induced expression of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in RBL-2H3 cells. eBV was also shown to suppress nitric oxide (NO) production by down-regulating mRNA expression and subsequent protein expression of inflammatory mediators in LPS-induced RAW 264.7 cells. Phosphorylation of activators and signal transducers of transcription 1/interferon regulatory factor 3 (STAT1/IRF3) was attenuated by eBV treatment. eBV significantly inhibited carrageenan-induced acute edema in vivo. Serum levels of prostaglandin E2 (PGE2), TNF-α, and IL-1β were also down-regulated by eBV. CONCLUSIONS: These results demonstrate that eBV inhibits allergic and inflammatory response by reducing inflammatory mediator production via regulation of the STAT1/IRF3 signaling pathway, suggesting that eBV is a feasible candidate for regulation of allergic-inflammatory response in complementary and alternative medicine.
format Online
Article
Text
id pubmed-5145209
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51452092016-12-22 In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model Chung, Hwa-Jin Lee, Jinho Shin, Joon-Shik Kim, Me-riong Koh, Wonil Kim, Min-Jeong Lee, Jae-woong Kim, Eun Jee Lee, In-Hee Kim, Won Kyung Lee, Yoon Jae Lee, Sang Kook Ha, In-Hyuk PLoS One Research Article BACKGROUND: Bee venom (BV), a type of toxin extracted from honeybees (Apis mellifera), has been empirically and widely used to treat inflammatory diseases throughout Asia. Essential BV (eBV) was developed by removing phospholipase A2 (PLA2) and histamine to lower occurrence of allergic reaction. This study investigated the anti-allergic and anti-inflammatory activities of eBV in vitro and in vivo and its underlying mechanism of action. METHODS: The anti-inflammatory potential of eBV was assessed in vivo using a carrageenan-induced paw edema model. To further investigate the mechanism by which eBV exerts anti-allergic and anti-inflammatory effects, compound 48/80-stimulated RBL-2H3 cells and lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophage cells were studied in vitro. RESULTS: Release of β-hexosaminidase and histamine was increased by eBV in a dose-dependent manner, but these levels were lower in eBV compared to original BV at the same concentration. In addition, eBV suppressed compound 48/80-induced expression of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in RBL-2H3 cells. eBV was also shown to suppress nitric oxide (NO) production by down-regulating mRNA expression and subsequent protein expression of inflammatory mediators in LPS-induced RAW 264.7 cells. Phosphorylation of activators and signal transducers of transcription 1/interferon regulatory factor 3 (STAT1/IRF3) was attenuated by eBV treatment. eBV significantly inhibited carrageenan-induced acute edema in vivo. Serum levels of prostaglandin E2 (PGE2), TNF-α, and IL-1β were also down-regulated by eBV. CONCLUSIONS: These results demonstrate that eBV inhibits allergic and inflammatory response by reducing inflammatory mediator production via regulation of the STAT1/IRF3 signaling pathway, suggesting that eBV is a feasible candidate for regulation of allergic-inflammatory response in complementary and alternative medicine. Public Library of Science 2016-12-08 /pmc/articles/PMC5145209/ /pubmed/27930719 http://dx.doi.org/10.1371/journal.pone.0168120 Text en © 2016 Chung et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chung, Hwa-Jin
Lee, Jinho
Shin, Joon-Shik
Kim, Me-riong
Koh, Wonil
Kim, Min-Jeong
Lee, Jae-woong
Kim, Eun Jee
Lee, In-Hee
Kim, Won Kyung
Lee, Yoon Jae
Lee, Sang Kook
Ha, In-Hyuk
In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model
title In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model
title_full In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model
title_fullStr In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model
title_full_unstemmed In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model
title_short In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model
title_sort in vitro and in vivo anti-allergic and anti-inflammatory effects of ebv, a newly developed derivative of bee venom, through modulation of irf3 signaling pathway in a carrageenan-induced edema model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145209/
https://www.ncbi.nlm.nih.gov/pubmed/27930719
http://dx.doi.org/10.1371/journal.pone.0168120
work_keys_str_mv AT chunghwajin invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT leejinho invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT shinjoonshik invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT kimmeriong invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT kohwonil invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT kimminjeong invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT leejaewoong invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT kimeunjee invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT leeinhee invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT kimwonkyung invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT leeyoonjae invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT leesangkook invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel
AT hainhyuk invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel